scispace - formally typeset
A

Aimin Xu

Researcher at University of Hong Kong

Publications -  542
Citations -  32145

Aimin Xu is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Adiponectin & Insulin resistance. The author has an hindex of 85, co-authored 493 publications receiving 27211 citations. Previous affiliations of Aimin Xu include Chinese Academy of Sciences & Zhejiang Wanli University.

Papers
More filters
Journal ArticleDOI

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

TL;DR: Adiponectin was effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice and could suppress the hepatic production of TNF-alpha and plasma concentrations of this proinflammatory cytokine.
Journal ArticleDOI

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

TL;DR: FGF21 is a novel adipokine associated with obesity-related metabolic complications in humans and the paradoxical increase of serum FGF21 in obese individuals, which may be explained by a compensatory response or resistance to FGF 21, warrants further investigation.
Journal ArticleDOI

Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice

TL;DR: The effects of FGF21 on attenuation of obesity-induced impairment in insulin signaling in liver and skeletal muscle were abrogated in adiponectin knockout mice, whereas F GF21-mediated activation of ERK1/ERK2 in adipose tissues remained unaffected.
Journal ArticleDOI

Value-added Utilisation of Waste Glass in Concrete

TL;DR: In this article, a fine glass powder (GLP) was used for incorporation into concrete as a pozzolanic material to suppress the alkali reactivity of coarser glass particles as well as that of natural reactive aggregates.
Journal ArticleDOI

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

TL;DR: A-fABP is a circulating biomarker closely associated with obesity and components of the metabolic syndrome, and measurement of serum concentrations of A-FABP might be useful for clinical diagnosis of obesity-related metabolic and cardiovascular disorders.